Last reviewed · How we verify
Other anti-psoriatic systemic treatments
Other anti-psoriatic systemic treatments is a Small molecule drug developed by Swiss Dermatology Network for Targeted Therapies. It is currently in Phase 2 development.
At a glance
| Generic name | Other anti-psoriatic systemic treatments |
|---|---|
| Sponsor | Swiss Dermatology Network for Targeted Therapies |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
- Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
- Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Other anti-psoriatic systemic treatments CI brief — competitive landscape report
- Other anti-psoriatic systemic treatments updates RSS · CI watch RSS
- Swiss Dermatology Network for Targeted Therapies portfolio CI
Frequently asked questions about Other anti-psoriatic systemic treatments
What is Other anti-psoriatic systemic treatments?
Other anti-psoriatic systemic treatments is a Small molecule drug developed by Swiss Dermatology Network for Targeted Therapies.
Who makes Other anti-psoriatic systemic treatments?
Other anti-psoriatic systemic treatments is developed by Swiss Dermatology Network for Targeted Therapies (see full Swiss Dermatology Network for Targeted Therapies pipeline at /company/swiss-dermatology-network-for-targeted-therapies).
What development phase is Other anti-psoriatic systemic treatments in?
Other anti-psoriatic systemic treatments is in Phase 2.